CEO, Academic Founder and Executive Board Member, Pepgen
Following work in genetics in both the private and public setting, Caroline completed her PhD at University College London under the supervision of Professor Francesco Muntoni. Caroline then moved to the University of Oxford to develop drug delivery technologies. This work was conducted under the guidance of Professor Matthew Wood and Dr Mike Gait, and served as a major part of the research underpinning PepGen’s technology platform. Caroline played a key role in the establishment of PepGen, and was instrumental in raising investment to support the company’s growth and development.